Pacific Biosciences Of California, Inc. financial data

Symbol
PACB on Nasdaq
Industry
Laboratory Analytical Instruments
Location
1305 O'brien Drive, Menlo Park, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
NANOFLUIDICS INC (to 7/28/2004)
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 859 % +132%
Quick Ratio 84.3 % +234%
Debt-to-equity 178 % -0.45%
Return On Equity -68.7 % -47.8%
Return On Assets -24.7 % -48.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 274M shares +2.4%
Common Stock, Shares, Outstanding 274M shares +5.98%
Common Stock, Value, Issued 274K USD +6.2%
Weighted Average Number of Shares Outstanding, Basic 273M shares +7.03%
Weighted Average Number of Shares Outstanding, Diluted 273M shares +7.03%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 40M USD -28.2%
Cost of Revenue 136M USD +12.5%
Research and Development Expense 152M USD -17.9%
Operating Income (Loss) -409M USD -22.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -395M USD -23.5%
Income Tax Expense (Benefit) -718K USD +93.3%
Net Income (Loss) Attributable to Parent -394M USD -27.5%
Earnings Per Share, Basic -1.46 USD/shares -15%
Earnings Per Share, Diluted -1.46 USD/shares -15%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 78M USD -79.8%
Accounts Receivable, after Allowance for Credit Loss, Current 29.4M USD -3.62%
Inventory, Net 65.7M USD -3.69%
Assets, Current 584M USD -33.8%
Property, Plant and Equipment, Net 32M USD -20.8%
Operating Lease, Right-of-Use Asset 17.3M USD -49.9%
Intangible Assets, Net (Excluding Goodwill) 436M USD -5.5%
Goodwill 369M USD -20.4%
Other Assets, Noncurrent 9.5M USD -26.9%
Assets 1.45B USD -23.6%
Accounts Payable, Current 12.1M USD -25.1%
Employee-related Liabilities, Current 29.3M USD +68.3%
Accrued Liabilities, Current 19.2M USD -44.7%
Contract with Customer, Liability, Current 17.3M USD -22.7%
Liabilities, Current 60M USD -67.4%
Contract with Customer, Liability, Noncurrent 5.46M USD +7.96%
Operating Lease, Liability, Noncurrent 16.9M USD -50.3%
Other Liabilities, Noncurrent 751K USD -28.5%
Liabilities 997M USD -12.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax 1.55M USD
Retained Earnings (Accumulated Deficit) -2.15B USD -22.4%
Stockholders' Equity Attributable to Parent 453M USD -40.7%
Liabilities and Equity 1.45B USD -23.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -75.7M USD +20.1%
Net Cash Provided by (Used in) Financing Activities 6.55M USD -96.7%
Net Cash Provided by (Used in) Investing Activities -34.1M USD +53%
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Shares, Issued 274M shares +5.98%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -103M USD -459%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 80.2M USD -79.3%
Deferred Tax Assets, Valuation Allowance 526M USD +18%
Deferred Tax Assets, Gross 642M USD +16%
Operating Lease, Liability 41.2M USD -17.5%
Depreciation 3.24M USD +17.6%
Payments to Acquire Property, Plant, and Equipment 3.88M USD +4.25%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -391M USD -28.3%
Lessee, Operating Lease, Liability, to be Paid 46.7M USD -20.2%
Property, Plant and Equipment, Gross 111M USD +4.37%
Operating Lease, Liability, Current 10.7M USD +12.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 12.3M USD +2.41%
Lessee, Operating Lease, Liability, to be Paid, Year One 12.1M USD +1.06%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 5.53M USD -35.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 12.4M USD +1.08%
Deferred Tax Assets, Operating Loss Carryforwards 435M USD +8.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Unrecognized Tax Benefits 14.6M USD +39.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 9.93M USD -19.9%
Additional Paid in Capital 2.6B USD +3.18%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 6.85M USD +2829%
Deferred Tax Assets, Net of Valuation Allowance 117M USD +7.61%
Share-based Payment Arrangement, Expense 71.6M USD -2.59%
Interest Expense 14.3M USD -2.29%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%